FDA says women who have these implants, but no symptoms, do not need to have them removed
Following a request by the U.S. Food and Drug Administration (FDA), Allergan voluntarily recalled BIOCELL® textured breast implants and tissue expanders due to uncommon incidence of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), a rare cancer of the immune system.
In recent years, textured, shaped breast implants are no longer considered the standard of care. The recall helps ensure that unused products are removed from suppliers and doctors’ offices. Currently, Summit Medical Group (SMG) exclusively uses smooth breast implants. But we recognize that our broad patient population could include potentially impacted individuals.
The FDA does not recommend removal or replacement of textured breast implants in asymptomatic patients because of the low incidence of ALCL and the potential risk of surgery.
Potentially impacted individuals are encouraged to talk to their doctor about their risks and options. We recommend that all breast implant recipients follow-up with their plastic surgeon every 1-2 years.
SMG patients with any questions regarding textured implants or ALCL should contact SMG’s Plastic Surgery Department at 908-277-8759.
Link to FDA Recall